These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 29922995
21. Quantitative Proteomic Profiling of Tachyplesin I Targets in U251 Gliomaspheres. Li X, Dai J, Tang Y, Li L, Jin G. Mar Drugs; 2017 Jan 18; 15(1):. PubMed ID: 28106765 [Abstract] [Full Text] [Related]
22. Comparison of Cytotoxic Activity in Leukemic Lineages Reveals Important Features of β-Hairpin Antimicrobial Peptides. Buri MV, Torquato HFV, Barros CC, Ide JS, Miranda A, Paredes-Gamero EJ. J Cell Biochem; 2017 Jul 18; 118(7):1764-1773. PubMed ID: 27987312 [Abstract] [Full Text] [Related]
25. Expression levels of antimicrobial peptide tachyplesin I in transgenic Ornithogalum lines affect the resistance to Pectobacterium infection. Lipsky A, Joshi JR, Carmi N, Yedidia I. J Biotechnol; 2016 Nov 20; 238():22-29. PubMed ID: 27639550 [Abstract] [Full Text] [Related]
28. Peptide-mediated leishmaniasis management strategy: Tachyplesin emerges as an effective anti-leishmanial peptide against Leishmania donovani. Kumar V, Chugh A. Biochim Biophys Acta Biomembr; 2021 Aug 01; 1863(8):183629. PubMed ID: 33933430 [Abstract] [Full Text] [Related]
29. The antimicrobial peptide tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model. Minardi D, Ghiselli R, Cirioni O, Giacometti A, Kamysz W, Orlando F, Silvestri C, Parri G, Kamysz E, Scalise G, Saba V, Giovanni M. Peptides; 2007 Dec 01; 28(12):2293-8. PubMed ID: 18022289 [Abstract] [Full Text] [Related]
30. Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds. Rao AG. Arch Biochem Biophys; 1999 Jan 01; 361(1):127-34. PubMed ID: 9882437 [Abstract] [Full Text] [Related]
33. Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework. Tam JP, Lu YA, Yang JL. Biochem Biophys Res Commun; 2000 Jan 27; 267(3):783-90. PubMed ID: 10673369 [Abstract] [Full Text] [Related]
34. Action mechanism of tachyplesin I and effects of PEGylation. Imura Y, Nishida M, Ogawa Y, Takakura Y, Matsuzaki K. Biochim Biophys Acta; 2007 May 27; 1768(5):1160-9. PubMed ID: 17320042 [Abstract] [Full Text] [Related]
36. Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties. Vernen F, Craik DJ, Lawrence N, Troeira Henriques S. ACS Chem Biol; 2019 Dec 20; 14(12):2895-2908. PubMed ID: 31714739 [Abstract] [Full Text] [Related]
38. Direct virus inactivation of tachyplesin I and its isopeptides from horseshoe crab hemocytes. Murakami T, Niwa M, Tokunaga F, Miyata T, Iwanaga S. Chemotherapy; 1991 Dec 20; 37(5):327-34. PubMed ID: 1666545 [Abstract] [Full Text] [Related]
39. Mode of action of an antimicrobial peptide, tachyplesin I, on biomembranes. Katsu T, Nakao S, Iwanaga S. Biol Pharm Bull; 1993 Feb 20; 16(2):178-81. PubMed ID: 7689887 [Abstract] [Full Text] [Related]
40. Tachyplesin I and its derivatives: A pharmaco-chemical perspective on their antimicrobial and antitumor potential. Lu S, Lin J, Jin J, Zhang L, Guan Y, Chen H, Wu Y, Zhang W, Luan X. Expert Opin Drug Discov; 2022 Dec 20; 17(12):1407-1423. PubMed ID: 36503335 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]